MedCap AB

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0009160872
SEK
544.00
47.5 (9.57%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Getinge AB
BONESUPPORT HOLDING AB
CellaVision AB
Surgical Science Sweden AB
Biotage AB
MedCap AB
Elekta AB
Vitrolife AB
Genovis AB
Bactiguard Holding AB
Xvivo Perfusion AB

Why is MedCap AB ?

1
Flat results in Jun 25
  • ROCE(HY) Lowest at 15.86%
  • INTEREST(Q) Highest at SEK 6.9 MM
2
With ROE of 15.26%, it has a very expensive valuation with a 6.21 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 31.24%, its profits have fallen by -3.4%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is MedCap AB for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
MedCap AB
31.24%
-0.06
37.15%
OMX Stockholm 30
17.06%
0.95
17.88%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
19.96%
EBIT Growth (5y)
29.85%
EBIT to Interest (avg)
10.65
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.16
Sales to Capital Employed (avg)
1.30
Tax Ratio
20.23%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
19.53%
ROE (avg)
14.67%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
41
Industry P/E
Price to Book Value
6.21
EV to EBIT
32.36
EV to EBITDA
21.60
EV to Capital Employed
7.31
EV to Sales
4.30
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
22.60%
ROE (Latest)
15.26%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company
OPERATING CASH FLOW(Y)

Highest at SEK 326 MM

RAW MATERIAL COST(Y)

Fallen by -5.37% (YoY

CASH AND EQV(HY)

Highest at SEK 650.3 MM

NET SALES(Q)

Highest at SEK 521.7 MM

OPERATING PROFIT(Q)

Highest at SEK 113 MM

OPERATING PROFIT MARGIN(Q)

Highest at 21.66 %

PRE-TAX PROFIT(Q)

Highest at SEK 74.4 MM

-6What is not working for the Company
ROCE(HY)

Lowest at 15.86%

INTEREST(Q)

Highest at SEK 6.9 MM

Here's what is working for MedCap AB

Operating Cash Flow
Highest at SEK 326 MM and Grown
In each year in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (SEK MM)

Net Sales
Highest at SEK 521.7 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (SEK MM)

Operating Profit
Highest at SEK 113 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (SEK MM)

Operating Profit Margin
Highest at 21.66 %
in the last five periods
MOJO Watch
Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit
Highest at SEK 74.4 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (SEK MM)

Cash and Eqv
Highest at SEK 650.3 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -5.37% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation
Highest at SEK 34.1 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (SEK MM)

Here's what is not working for MedCap AB

Interest
At SEK 6.9 MM has Grown at 50%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)

Interest
Highest at SEK 6.9 MM
in the last five periods and Increased by 50% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (SEK MM)